世界の腸内細菌叢市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gut Microbiome Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4274
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、腸内細菌叢の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肥満、炎症性腸疾患（IBD）、糖尿病、その他）、用途別市場規模（人間、動物）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・腸内細菌叢の市場動向
・企業の競争状況、市場シェア
・腸内細菌叢の種類別市場規模と予測2016-2027（肥満、炎症性腸疾患（IBD）、糖尿病、その他）
・腸内細菌叢の用途別市場規模と予測2016-2027（人間、動物）
・腸内細菌叢の北米市場規模2016-2027（アメリカ、カナダ）
・腸内細菌叢の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・腸内細菌叢のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・腸内細菌叢の中南米市場規模2016-2027（メキシコ、ブラジル）
・腸内細菌叢の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Viome、Carbiotix、Ixcela, Inc、Novome Biotechnologies、Kintai Therapeutics、ProDigest、Caelus Health、LNC Therapeutics、AnimalBiome、Assembly Biosciences、Enterome BioScience）
・結論

The gut microbiome is a vast ecosystem of organisms such as bacteria, yeasts, fungi, viruses and protozoans that live in our digestive pipes, which collectively weigh up to 2kg (heavier than the average brain). The report is about Gut Microbiome Therapeutics market.

Market Analysis and Insights: Global Gut Microbiome Market
The global Gut Microbiome market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gut Microbiome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gut Microbiome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gut Microbiome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gut Microbiome market.

Global Gut Microbiome Scope and Market Size
Gut Microbiome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gut Microbiome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Obesity
Inflammatory Bowel Disease (IBD)
Diabetes
Others

Segment by Application
Human
Animal

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Viome
Carbiotix
Ixcela, Inc
Novome Biotechnologies
Kintai Therapeutics
ProDigest
Caelus Health
LNC Therapeutics
AnimalBiome
Assembly Biosciences
Enterome BioScience

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gut Microbiome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Obesity
1.2.3 Inflammatory Bowel Disease (IBD)
1.2.4 Diabetes
1.2.5 Others
1.3 Market by Application
1.3.1 Global Gut Microbiome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Human
1.3.3 Animal
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gut Microbiome Market Perspective (2016-2027)
2.2 Gut Microbiome Growth Trends by Regions
2.2.1 Gut Microbiome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gut Microbiome Historic Market Share by Regions (2016-2021)
2.2.3 Gut Microbiome Forecasted Market Size by Regions (2022-2027)
2.3 Gut Microbiome Industry Dynamic
2.3.1 Gut Microbiome Market Trends
2.3.2 Gut Microbiome Market Drivers
2.3.3 Gut Microbiome Market Challenges
2.3.4 Gut Microbiome Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gut Microbiome Players by Revenue
3.1.1 Global Top Gut Microbiome Players by Revenue (2016-2021)
3.1.2 Global Gut Microbiome Revenue Market Share by Players (2016-2021)
3.2 Global Gut Microbiome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gut Microbiome Revenue
3.4 Global Gut Microbiome Market Concentration Ratio
3.4.1 Global Gut Microbiome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gut Microbiome Revenue in 2020
3.5 Gut Microbiome Key Players Head office and Area Served
3.6 Key Players Gut Microbiome Product Solution and Service
3.7 Date of Enter into Gut Microbiome Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gut Microbiome Breakdown Data by Type
4.1 Global Gut Microbiome Historic Market Size by Type (2016-2021)
4.2 Global Gut Microbiome Forecasted Market Size by Type (2022-2027)

5 Gut Microbiome Breakdown Data by Application
5.1 Global Gut Microbiome Historic Market Size by Application (2016-2021)
5.2 Global Gut Microbiome Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gut Microbiome Market Size (2016-2027)
6.2 North America Gut Microbiome Market Size by Type
6.2.1 North America Gut Microbiome Market Size by Type (2016-2021)
6.2.2 North America Gut Microbiome Market Size by Type (2022-2027)
6.2.3 North America Gut Microbiome Market Size by Type (2016-2027)
6.3 North America Gut Microbiome Market Size by Application
6.3.1 North America Gut Microbiome Market Size by Application (2016-2021)
6.3.2 North America Gut Microbiome Market Size by Application (2022-2027)
6.3.3 North America Gut Microbiome Market Size by Application (2016-2027)
6.4 North America Gut Microbiome Market Size by Country
6.4.1 North America Gut Microbiome Market Size by Country (2016-2021)
6.4.2 North America Gut Microbiome Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Gut Microbiome Market Size (2016-2027)
7.2 Europe Gut Microbiome Market Size by Type
7.2.1 Europe Gut Microbiome Market Size by Type (2016-2021)
7.2.2 Europe Gut Microbiome Market Size by Type (2022-2027)
7.2.3 Europe Gut Microbiome Market Size by Type (2016-2027)
7.3 Europe Gut Microbiome Market Size by Application
7.3.1 Europe Gut Microbiome Market Size by Application (2016-2021)
7.3.2 Europe Gut Microbiome Market Size by Application (2022-2027)
7.3.3 Europe Gut Microbiome Market Size by Application (2016-2027)
7.4 Europe Gut Microbiome Market Size by Country
7.4.1 Europe Gut Microbiome Market Size by Country (2016-2021)
7.4.2 Europe Gut Microbiome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gut Microbiome Market Size (2016-2027)
8.2 Asia-Pacific Gut Microbiome Market Size by Type
8.2.1 Asia-Pacific Gut Microbiome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gut Microbiome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gut Microbiome Market Size by Type (2016-2027)
8.3 Asia-Pacific Gut Microbiome Market Size by Application
8.3.1 Asia-Pacific Gut Microbiome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gut Microbiome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gut Microbiome Market Size by Application (2016-2027)
8.4 Asia-Pacific Gut Microbiome Market Size by Region
8.4.1 Asia-Pacific Gut Microbiome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gut Microbiome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gut Microbiome Market Size (2016-2027)
9.2 Latin America Gut Microbiome Market Size by Type
9.2.1 Latin America Gut Microbiome Market Size by Type (2016-2021)
9.2.2 Latin America Gut Microbiome Market Size by Type (2022-2027)
9.2.3 Latin America Gut Microbiome Market Size by Type (2016-2027)
9.3 Latin America Gut Microbiome Market Size by Application
9.3.1 Latin America Gut Microbiome Market Size by Application (2016-2021)
9.3.2 Latin America Gut Microbiome Market Size by Application (2022-2027)
9.3.3 Latin America Gut Microbiome Market Size by Application (2016-2027)
9.4 Latin America Gut Microbiome Market Size by Country
9.4.1 Latin America Gut Microbiome Market Size by Country (2016-2021)
9.4.2 Latin America Gut Microbiome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gut Microbiome Market Size (2016-2027)
10.2 Middle East & Africa Gut Microbiome Market Size by Type
10.2.1 Middle East & Africa Gut Microbiome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gut Microbiome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gut Microbiome Market Size by Type (2016-2027)
10.3 Middle East & Africa Gut Microbiome Market Size by Application
10.3.1 Middle East & Africa Gut Microbiome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gut Microbiome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gut Microbiome Market Size by Application (2016-2027)
10.4 Middle East & Africa Gut Microbiome Market Size by Country
10.4.1 Middle East & Africa Gut Microbiome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gut Microbiome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Viome
11.1.1 Viome Company Details
11.1.2 Viome Business Overview
11.1.3 Viome Gut Microbiome Introduction
11.1.4 Viome Revenue in Gut Microbiome Business (2016-2021)
11.1.5 Viome Recent Development
11.2 Carbiotix
11.2.1 Carbiotix Company Details
11.2.2 Carbiotix Business Overview
11.2.3 Carbiotix Gut Microbiome Introduction
11.2.4 Carbiotix Revenue in Gut Microbiome Business (2016-2021)
11.2.5 Carbiotix Recent Development
11.3 Ixcela, Inc
11.3.1 Ixcela, Inc Company Details
11.3.2 Ixcela, Inc Business Overview
11.3.3 Ixcela, Inc Gut Microbiome Introduction
11.3.4 Ixcela, Inc Revenue in Gut Microbiome Business (2016-2021)
11.3.5 Ixcela, Inc Recent Development
11.4 Novome Biotechnologies
11.4.1 Novome Biotechnologies Company Details
11.4.2 Novome Biotechnologies Business Overview
11.4.3 Novome Biotechnologies Gut Microbiome Introduction
11.4.4 Novome Biotechnologies Revenue in Gut Microbiome Business (2016-2021)
11.4.5 Novome Biotechnologies Recent Development
11.5 Kintai Therapeutics
11.5.1 Kintai Therapeutics Company Details
11.5.2 Kintai Therapeutics Business Overview
11.5.3 Kintai Therapeutics Gut Microbiome Introduction
11.5.4 Kintai Therapeutics Revenue in Gut Microbiome Business (2016-2021)
11.5.5 Kintai Therapeutics Recent Development
11.6 ProDigest
11.6.1 ProDigest Company Details
11.6.2 ProDigest Business Overview
11.6.3 ProDigest Gut Microbiome Introduction
11.6.4 ProDigest Revenue in Gut Microbiome Business (2016-2021)
11.6.5 ProDigest Recent Development
11.7 Caelus Health
11.7.1 Caelus Health Company Details
11.7.2 Caelus Health Business Overview
11.7.3 Caelus Health Gut Microbiome Introduction
11.7.4 Caelus Health Revenue in Gut Microbiome Business (2016-2021)
11.7.5 Caelus Health Recent Development
11.8 LNC Therapeutics
11.8.1 LNC Therapeutics Company Details
11.8.2 LNC Therapeutics Business Overview
11.8.3 LNC Therapeutics Gut Microbiome Introduction
11.8.4 LNC Therapeutics Revenue in Gut Microbiome Business (2016-2021)
11.8.5 LNC Therapeutics Recent Development
11.9 AnimalBiome
11.9.1 AnimalBiome Company Details
11.9.2 AnimalBiome Business Overview
11.9.3 AnimalBiome Gut Microbiome Introduction
11.9.4 AnimalBiome Revenue in Gut Microbiome Business (2016-2021)
11.9.5 AnimalBiome Recent Development
11.10 Assembly Biosciences
11.10.1 Assembly Biosciences Company Details
11.10.2 Assembly Biosciences Business Overview
11.10.3 Assembly Biosciences Gut Microbiome Introduction
11.10.4 Assembly Biosciences Revenue in Gut Microbiome Business (2016-2021)
11.10.5 Assembly Biosciences Recent Development
11.11 Enterome BioScience
11.11.1 Enterome BioScience Company Details
11.11.2 Enterome BioScience Business Overview
11.11.3 Enterome BioScience Gut Microbiome Introduction
11.11.4 Enterome BioScience Revenue in Gut Microbiome Business (2016-2021)
11.11.5 Enterome BioScience Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gut Microbiome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Obesity
Table 3. Key Players of Inflammatory Bowel Disease (IBD)
Table 4. Key Players of Diabetes
Table 5. Key Players of Others
Table 6. Global Gut Microbiome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Gut Microbiome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Gut Microbiome Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Gut Microbiome Market Share by Regions (2016-2021)
Table 10. Global Gut Microbiome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Gut Microbiome Market Share by Regions (2022-2027)
Table 12. Gut Microbiome Market Trends
Table 13. Gut Microbiome Market Drivers
Table 14. Gut Microbiome Market Challenges
Table 15. Gut Microbiome Market Restraints
Table 16. Global Gut Microbiome Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Gut Microbiome Market Share by Players (2016-2021)
Table 18. Global Top Gut Microbiome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gut Microbiome as of 2020)
Table 19. Ranking of Global Top Gut Microbiome Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Gut Microbiome Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Gut Microbiome Product Solution and Service
Table 23. Date of Enter into Gut Microbiome Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gut Microbiome Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Gut Microbiome Revenue Market Share by Type (2016-2021)
Table 27. Global Gut Microbiome Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Gut Microbiome Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Gut Microbiome Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Gut Microbiome Revenue Market Share by Application (2016-2021)
Table 31. Global Gut Microbiome Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Gut Microbiome Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Gut Microbiome Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Gut Microbiome Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Gut Microbiome Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Gut Microbiome Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Gut Microbiome Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Gut Microbiome Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Gut Microbiome Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Gut Microbiome Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Gut Microbiome Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Gut Microbiome Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Gut Microbiome Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Gut Microbiome Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gut Microbiome Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gut Microbiome Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gut Microbiome Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Gut Microbiome Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Gut Microbiome Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Gut Microbiome Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Gut Microbiome Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Gut Microbiome Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Gut Microbiome Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Gut Microbiome Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Gut Microbiome Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Gut Microbiome Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gut Microbiome Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gut Microbiome Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gut Microbiome Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Gut Microbiome Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Gut Microbiome Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Gut Microbiome Market Size by Country (2022-2027) & (US$ Million)
Table 63. Viome Company Details
Table 64. Viome Business Overview
Table 65. Viome Gut Microbiome Product
Table 66. Viome Revenue in Gut Microbiome Business (2016-2021) & (US$ Million)
Table 67. Viome Recent Development
Table 68. Carbiotix Company Details
Table 69. Carbiotix Business Overview
Table 70. Carbiotix Gut Microbiome Product
Table 71. Carbiotix Revenue in Gut Microbiome Business (2016-2021) & (US$ Million)
Table 72. Carbiotix Recent Development
Table 73. Ixcela, Inc Company Details
Table 74. Ixcela, Inc Business Overview
Table 75. Ixcela, Inc Gut Microbiome Product
Table 76. Ixcela, Inc Revenue in Gut Microbiome Business (2016-2021) & (US$ Million)
Table 77. Ixcela, Inc Recent Development
Table 78. Novome Biotechnologies Company Details
Table 79. Novome Biotechnologies Business Overview
Table 80. Novome Biotechnologies Gut Microbiome Product
Table 81. Novome Biotechnologies Revenue in Gut Microbiome Business (2016-2021) & (US$ Million)
Table 82. Novome Biotechnologies Recent Development
Table 83. Kintai Therapeutics Company Details
Table 84. Kintai Therapeutics Business Overview
Table 85. Kintai Therapeutics Gut Microbiome Product
Table 86. Kintai Therapeutics Revenue in Gut Microbiome Business (2016-2021) & (US$ Million)
Table 87. Kintai Therapeutics Recent Development
Table 88. ProDigest Company Details
Table 89. ProDigest Business Overview
Table 90. ProDigest Gut Microbiome Product
Table 91. ProDigest Revenue in Gut Microbiome Business (2016-2021) & (US$ Million)
Table 92. ProDigest Recent Development
Table 93. Caelus Health Company Details
Table 94. Caelus Health Business Overview
Table 95. Caelus Health Gut Microbiome Product
Table 96. Caelus Health Revenue in Gut Microbiome Business (2016-2021) & (US$ Million)
Table 97. Caelus Health Recent Development
Table 98. LNC Therapeutics Company Details
Table 99. LNC Therapeutics Business Overview
Table 100. LNC Therapeutics Revenue in Gut Microbiome Business (2016-2021) & (US$ Million)
Table 101. LNC Therapeutics Recent Development
Table 102. AnimalBiome Company Details
Table 103. AnimalBiome Business Overview
Table 104. AnimalBiome Gut Microbiome Product
Table 105. AnimalBiome Revenue in Gut Microbiome Business (2016-2021) & (US$ Million)
Table 106. AnimalBiome Recent Development
Table 107. Assembly Biosciences Company Details
Table 108. Assembly Biosciences Business Overview
Table 109. Assembly Biosciences Gut Microbiome Product
Table 110. Assembly Biosciences Revenue in Gut Microbiome Business (2016-2021) & (US$ Million)
Table 111. Assembly Biosciences Recent Development
Table 112. Enterome BioScience Company Details
Table 113. Enterome BioScience Business Overview
Table 114. Enterome BioScience Gut Microbiome Product
Table 115. Enterome BioScience Revenue in Gut Microbiome Business (2016-2021) & (US$ Million)
Table 116. Enterome BioScience Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gut Microbiome Market Share by Type: 2020 VS 2027
Figure 2. Obesity Features
Figure 3. Inflammatory Bowel Disease (IBD) Features
Figure 4. Diabetes Features
Figure 5. Others Features
Figure 6. Global Gut Microbiome Market Share by Application: 2020 VS 2027
Figure 7. Human Case Studies
Figure 8. Animal Case Studies
Figure 9. Gut Microbiome Report Years Considered
Figure 10. Global Gut Microbiome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Gut Microbiome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Gut Microbiome Market Share by Regions: 2020 VS 2027
Figure 13. Global Gut Microbiome Market Share by Regions (2022-2027)
Figure 14. Global Gut Microbiome Market Share by Players in 2020
Figure 15. Global Top Gut Microbiome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gut Microbiome as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Gut Microbiome Revenue in 2020
Figure 17. Global Gut Microbiome Revenue Market Share by Type (2016-2021)
Figure 18. Global Gut Microbiome Revenue Market Share by Type (2022-2027)
Figure 19. North America Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Gut Microbiome Market Share by Type (2016-2027)
Figure 21. North America Gut Microbiome Market Share by Application (2016-2027)
Figure 22. North America Gut Microbiome Market Share by Country (2016-2027)
Figure 23. United States Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gut Microbiome Market Share by Type (2016-2027)
Figure 27. Europe Gut Microbiome Market Share by Application (2016-2027)
Figure 28. Europe Gut Microbiome Market Share by Country (2016-2027)
Figure 29. Germany Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gut Microbiome Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Gut Microbiome Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Gut Microbiome Market Share by Region (2016-2027)
Figure 39. China Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gut Microbiome Market Share by Type (2016-2027)
Figure 47. Latin America Gut Microbiome Market Share by Application (2016-2027)
Figure 48. Latin America Gut Microbiome Market Share by Country (2016-2027)
Figure 49. Mexico Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gut Microbiome Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Gut Microbiome Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Gut Microbiome Market Share by Country (2016-2027)
Figure 55. Turkey Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Gut Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Viome Revenue Growth Rate in Gut Microbiome Business (2016-2021)
Figure 59. Carbiotix Revenue Growth Rate in Gut Microbiome Business (2016-2021)
Figure 60. Ixcela, Inc Revenue Growth Rate in Gut Microbiome Business (2016-2021)
Figure 61. Novome Biotechnologies Revenue Growth Rate in Gut Microbiome Business (2016-2021)
Figure 62. Kintai Therapeutics Revenue Growth Rate in Gut Microbiome Business (2016-2021)
Figure 63. ProDigest Revenue Growth Rate in Gut Microbiome Business (2016-2021)
Figure 64. Caelus Health Revenue Growth Rate in Gut Microbiome Business (2016-2021)
Figure 65. LNC Therapeutics Revenue Growth Rate in Gut Microbiome Business (2016-2021)
Figure 66. AnimalBiome Revenue Growth Rate in Gut Microbiome Business (2016-2021)
Figure 67. Assembly Biosciences Revenue Growth Rate in Gut Microbiome Business (2016-2021)
Figure 68. Enterome BioScience Revenue Growth Rate in Gut Microbiome Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界の直接消費者用微生物叢分析市場規模・現状・予測（2021年-2027年）

Global Direct to Consumer Microbiome Analyzing Market Size, Status and Forecast 2021-2027
QFJ1-4138 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、直接消費者用微生物叢分析の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（腸内微生物叢検査キット、健康サンプルキット、その他微生物叢検査キット）、用途別市場規模（感染症、腸の状態、代謝障害、心血管疾患、...

世界の微生物叢診断市場規模・現状・予測（2021年-2027年）

Global Microbiome Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-5251 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、微生物叢診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ゲノミクス、プロテオミクス、メタボロミクス）、用途別市場規模（感染症、内分泌・代謝性疾患、炎症性疾患、がん）、主要地域別市場規模（北米、アメ...

世界の微生物叢治療市場規模・現状・予測（2021年-2027年）

Global Microbiome Therapies Market Size, Status and Forecast 2021-2027
QFJ1-5252 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、微生物叢治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バクテリア、真菌、ウイルス、その他）、用途別市場規模（試験所、研究所、園芸、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界のヒトマイクロバイオーム治療薬市場規模・現状・予測（2021年-2027年）

Global Human Microbiome Therapeutic Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4332 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、ヒトマイクロバイオーム治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（FMT、マイクロバイオーム医薬品、その他）、用途別市場規模（胃、口腔、気道、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界の動物ミクロビオーム市場規模・現状・予測（2021年-2027年）

Global Animal Microbiome Market Size, Status and Forecast 2021-2027
QFJ1-5080 2021年6月 116Pages
QYResearch社発行の本調査レポートでは、動物ミクロビオームの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（テストサービス、補足製品）、用途別市場規模（慢性下痢、便秘、嘔吐、皮膚状態、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の皮膚用マイクロバイオームモジュレーター市場規模・現状・予測（2021年-2027年）

Global Skin Microbiome Modulator Market Size, Status and Forecast 2021-2027
QFJ1-4868 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、皮膚用マイクロバイオームモジュレーターの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プロバイオティクス、プレバイオティクス、医薬品）、用途別市場規模（スキンケア、ヘアケア、その他）、主要地域別市場規...

世界のロミプロスティム市場規模・現状・予測（2021年-2027年）

Global Romiplostim Market Size, Status and Forecast 2021-2027
QFJ1-5998 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、ロミプロスティムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250μg/ 0.5mL、500μg/ 1mL）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のラパチニブ市場規模・現状・予測（2021年-2027年）

Global Lapatinib Market Size, Status and Forecast 2021-2027
QFJ1-5828 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ラパチニブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250mg錠、タイプII）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のパニツムマブ市場規模・現状・予測（2021年-2027年）

Global Panitumumab Market Size, Status and Forecast 2021-2027
QFJ1-5929 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、パニツムマブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（100mg/5ml単回投与バイアル、400mg/20ml単回投与バイアル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米...

世界のレタパムリン市場規模・現状・予測（2021年-2027年）

Global Retapamulin Market Size, Status and Forecast 2021-2027
QFJ1-5992 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、レタパムリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（1％軟膏（15グラムチューブ）、1％軟膏（30グラムチューブ））、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ...

世界のヒトマイクロバイオーム治療薬市場規模・現状・予測（2021年-2027年） Human microbiome therapeutic drugs are drugs made by using the relationship between the gene content of the microbiota and metabolic activities. Market Analysis and Insights: Global Human Microbiome Therapeutic Drugs Market The global Human Microbiome Therapeutic Drugs market size is projected to re…
世界の動物ミクロビオーム市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Animal Microbiome Market The global Animal Microbiome market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…
世界の直接消費者用微生物叢分析市場規模・現状・予測（2021年-2027年） Direct to Consumer Microbiome Analyzing is analyzing the microbes in consumers’ sample, then consumers can get a report on how microbiome works in their body. Market Analysis and Insights: Global Direct to Consumer Microbiome Analyzing Market The global Direct to Consumer Microbiome Analyzing market…
世界の微生物叢診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Microbiome Diagnostics Market The global Microbiome Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…
世界の微生物叢治療市場規模・現状・予測（2021年-2027年） Microbiome is a collective genome of microorganisms that reside inside and outside of the body, ranging from pathogenic to beneficial. Market Analysis and Insights: Global Microbiome Therapies Market The global Microbiome Therapies market size is projected to reach US$ XX million by 2027, from US$ X…